HER-2 ADC

Clinical trials for HER-2 ADC explained in plain language.

Never miss a new study

Get alerted when new HER-2 ADC trials appear

Sign up with your email to follow new studies for HER-2 ADC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to spare kidneys in High-Risk urinary tract cancer

Disease control Recruiting now

This phase 2 trial tests two drugs—RC48 and Tislelizumab—given before kidney-sparing surgery in 20 people with high-risk upper tract urothelial carcinoma. The goal is to control the cancer while preserving the kidney, avoiding complete removal. Researchers will track how long pat…

Matched conditions: HER-2 ADC

Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control

Last updated Jun 27, 2026 08:03 UTC

HER-2 ADC

Get alerted when new HER-2 ADC trials appear

New drug combo aims to spare kidneys in High-Risk urinary tract cancer